SCHEMBL6720109

SCHEMBL6720109

Cc1nc(-c2cccnc2-c2ccc(CS(=O)(=O)Cc3ccc(-c4ncccc4-c4csc(C)n4)cc3F)c(F)c2)cs1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 2/20 0.39
ALOX5AP P20292 3/20 0.37
FEN1 P39748 3/20 0.37
ALDH1A1 P00352 1/20 0.36
GFER P55789 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.35
TGFBR1 P36897 1/20 0.35
MAPT P10636 1/20 0.35
KDM4E B2RXH2 2/20 0.35
PKM P14618 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GRM4 Q14833 2/20 0.35
EIF4E P06730 1/20 0.34
PDE4A P27815 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6729350 0.84 TGFBR1 (0.40) ALOX5APFEN1ALDH1A1TGFBR1KDM4E
SCHEMBL6721827 0.83 PDE3B (0.41) ALOX5APFEN1TGFBR1GRM4
SCHEMBL7045462 0.83 SCN9A (0.45) SCN9AALOX5APFEN1HPGDHTT
SCHEMBL6719334 0.83 TGFBR1 (0.46) ALOX5APFEN1TGFBR1
SCHEMBL6718990 0.82 SCN9A (0.44) SCN9AALOX5APFEN1ALDH1A1HPGD
SCHEMBL6730013 0.81 PTGS2 (0.43) ALOX5APFEN1TGFBR1
SCHEMBL6721436 0.80 PTGS2 (0.40) ALOX5APFEN1TGFBR1
SCHEMBL6723509 0.80 FEN1 (0.40) ALOX5APFEN1TGFBR1
SCHEMBL6722778 0.80 RPS6KA3 (0.38) ALOX5APFEN1ALDH1A1GFERHPGD
SCHEMBL6749607 0.80 SCN9A (0.40) SCN9AALOX5APFEN1ALDH1A1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation FPR2, PTGES2, FPR1 SCN9A 4401/4885ALOX5AP 395/4885FEN1 1713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.